Table 3 Sub-cohort and case group Wave 1 HHV-8 seropositivity, by age and Wave 1 PSA result
From: A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago
| Â | Â | Cases | Sub-cohort | ||||
|---|---|---|---|---|---|---|---|
Age years | PSA ng/mL | Â | HHV-8 positive | Â | HHV-8 positive | ||
| Â | Â | n | n | % | n | n | % |
40-49 | All | 12 | 0 | 0.0 | 200 | 7 | 3.5 |
50-59 | All | 37 | 4 | 10.8 | 110 | 15 | 13.6 |
≥ 60 | All | 47 | 13 | 27.7 | 105 | 24 | 22.9 |
All | < 4 | 70 | 12 | 17.1 | 392 | 39 | 9.9 |
All | ≥ 4 | 26 | 5 | 19.2 | 23 | 7 | 30.4 |
40-49 | < 4 | 12 | 0 | 0.0 | 197 | 6 | 3.0 |
50-59 | < 4 | 26 | 3 | 11.5 | 102 | 14 | 13.7 |
≥ 60 | < 4 | 32 | 9 | 28.1 | 93 | 19 | 20.4 |
40-49 | ≥ 4 |  |  |  | 3 | 1 | 33.3 |
50-59 | ≥ 4 | 11 | 1 | 9.1 | 8 | 1 | 12.5 |
≥ 60 | ≥ 4 | 15 | 4 | 26.7 | 12 | 5 | 41.7 |